Back to mobile site

Wells Fargo Starts OncoMed Pharmaceuticals (OMED) at Outperform

December 3, 2015 5:15 PM EST Send to a Friend
Wells Fargo initiated coverage on OncoMed Pharmaceuticals (NASDAQ: OMED) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login